Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application

•Clinical applications for tissue engineered vascular grafts (TEVG) include arterial bypass and hemodialysis access.•TEVGs must be non-antigenic, durable, cost-effective, and remain patent to be feasible.•Advances in cell culture, scaffolds, biomaterials, and manufacturing enhance TEVG feasibility.•Newer technologies such as electrospinning and 3D-printing are available to manufacture TEVG.